Director James D. Forbes files initial Form 3 at DENTSPLY SIRONA (XRAY)

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director James D. Forbes filed an initial ownership report on Form 3. This filing establishes his status as an insider, including his role as a director of the company. The Form 3 does not report any share purchases or sales, and serves as a baseline disclosure of his insider position.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Forbes James D

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/27/2026

3. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for James D. Forbes	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the DENTSPLY SIRONA (XRAY) Form 3 for James D. Forbes show?

The Form 3 shows that James D. Forbes is a director of DENTSPLY SIRONA Inc. It is an initial insider ownership report and does not list any share purchases or sales.

Did James D. Forbes buy or sell XRAY shares in this Form 3 filing?

No, this Form 3 does not report any share purchases or sales by James D. Forbes. It only records his status as a company director and establishes his insider reporting obligations.

Why did DENTSPLY SIRONA director James D. Forbes file a Form 3?

James D. Forbes filed Form 3 because, as a director of DENTSPLY SIRONA Inc., he must disclose his insider status. Form 3 is the initial statement of beneficial ownership required under U.S. securities rules.

Does the XRAY Form 3 for James D. Forbes indicate his role at the company?

Yes, the filing identifies James D. Forbes as a director of DENTSPLY SIRONA Inc. This confirms he is considered an insider and subject to ongoing ownership reporting requirements.

Are any share amounts or transactions detailed in the XRAY Form 3 for James D. Forbes?

No specific share purchases or sales are detailed in this Form 3. The report focuses on establishing James D. Forbes as a director and initial insider, without listing transactional activity.